ArticleOncotarget2017

Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN.

Andrea Cavazzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.